Download
1 / 5
50 likes | 60 Views
ElectroceuticalsBioelectric Medicine Market
E N D
Electroceuticals/Bio electric Medicine Market To Reach USD 38.13 Billion By 2026 www.reportsanddata.com
Market Summary Bioelectric medicine or Electroceuticals devices indicates the usage of devices instead of drugs, are safe to block, record and stimulate neural signals to cure from chronic disorders. They are invasive and non- invasive in nature which are held against the skin or implanted in nerve to restore the healthy condition of the patient without the complicated side of pharmaceutical agents. They treat diseases by the implication of devices which combine bioengineering, neuroscience, molecular medicines and electronics for the regulation of biological process. The bioelectric therapy also prompts the body to produce endorphins which helps to relieve pain in the body of the patients. So, usually there’s an inflammation which is the central phenomenon in all diseases starting from cancer to diabetes and secondly, this inflammation can be controlled through electrically stimulating vagus nerve. Electroceutical devices are used for the treatment of epilepsy, cardiovascular diseases, cancer, paralysis, rheumatoid arthritis and diabetes, etc. www.reportsanddata.com Read More: https://www.reportsanddata.com/report-detail/electroceuticals-bioelectric- medicine-market
Market Summary Further key findings from the report suggest • Europe is the second largest region with a share of 31.0 % due to the high cases of mergers and acquisitions and advancements in R&D • Cardiac Pacemakers is accounted to be the second leading segment which is valued at USD 5411.7 million due to increasing number of patients with cardiac disorders and a huge demand and supply of implantable cardiac pacemakers across the regions • Hospitals segment has dominated the market in 2018 and will continue to do the same in the forecasted years • North America is expected to account for the 48.8% of the global Electroceuticals/Bioelectric Medicine market million owing to the prevalence increase in geriatric population, FDA approvals for retinal implants • Implantable Electroceuticals Devices segment holds the largest share in this market which is valued at USD 18886.2 million due to its large usage to cure arrhythmia, sensorineural hearing loss, tremor, ischemia etc • Key participants include Biotronic, GlaxoSmithKline, Medtronic PLC and Siemens AG www.reportsanddata.com
Market Summary Devices Type (Revenue, USD Million; 2016–2026) Implantable Electroceutical Devices Non-Invasive Electroceutical Devices • • • Application (Revenue, USD Million; 2016–2026) Pain Management Depression Epilepsy Arrhythmia Tremor Parkinson’s Disease SensorineuralHearing Loss Urinary and Fecal Incontinence Menstrual migraine Retinitis Pigmentosa Spinal Cord Injury Others • • • • • • • • • • • • • www.reportsanddata.com
About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. Contact US Contact US We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. www.reportsanddata.com John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com
